Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas

NCT03600649 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Salarius Pharmaceuticals, LLC

Collaborators